Innovex secondary offering of 5.75M shares at $25.75; co. repurchases 575k shares for $14.1M

Innovex International, Inc.

Selling stockholders (Amberjack affiliates) sold 5,750,000 shares at $25.75; underwriters exercised option for 862,500 shares fully.
Company did not receive any proceeds from the secondary offering.
Company repurchased 575,000 shares from underwriters for ~$14.1M under existing buyback program.
After repurchase, $76.6M remains under share repurchase program.

Key facts

Extracted from this filing and checked against the source text.

Material Agreements SEC 8-K Item 1.01/1.02 confidence 0.9

Innovex International, Inc. entered into Underwriting Agreement with certain affiliates of Amberjack Capital Partners, L.P. and J.P. Morgan Securities LLC, as representative of the several underwriters (effective 2026-02-25).

Action: entry
Agreement: underwriting
Counterparty: certain affiliates of Amberjack Capital Partners, L.P. and J.P. Morgan Securities LLC, as representative of the several underwriters
Effective: 2026-02-25

Exact text from the filing

On February 25, 2026, Innovex International, Inc. (the “Company”) entered into an Underwriting Agreement (the “Underwriting Agreement”) with certain affiliates of Amberjack Capital Partners, L.P. (the “Selling Stockholders”) and J.P. Morgan Securities LLC, as representative of the several underwriters listed on Schedule 1 thereto (the “Underwriters”), relating to the offer and sale by the Selling Stockholders of 5,750,000 shares of common stock, par value $0.01 per share, of the Company (the “Common Stock”), at a price to the public of $25.75 per share (the “Offering”).

View on SEC.gov

291 material agreements filed in the last 30 days. Browse all material agreements →

Innovex International, Inc. filing history →

Source: SEC EDGAR

accession 0001193125-26-082802

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.